Asset Details
Do you wish to reserve the book?
Effectiveness and Safety of Dapagliflozin for Black and White Patients With Chronic Kidney Disease in North and South America
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effectiveness and Safety of Dapagliflozin for Black and White Patients With Chronic Kidney Disease in North and South America
Do you wish to request the book?
Effectiveness and Safety of Dapagliflozin for Black and White Patients With Chronic Kidney Disease in North and South America
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effectiveness and Safety of Dapagliflozin for Black and White Patients With Chronic Kidney Disease in North and South America
2023
Overview
This secondary analysis of a randomized clinical trial investigates the relative effectiveness and safety of the sodium-glucose cotransporter-2 inhibitor dapagliflozin for Black and White patients with chronic kidney disease (CKD) in North and South America.
Publisher
American Medical Association
Subject
We currently cannot retrieve any items related to this title. Kindly check back at a later time.